C157H170F2N30O7 — CID 157093225
4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide (PubChem CID 157093225) has the molecular formula C157H170F2N30O7 and a molecular weight of 2627.29 g/mol. Its IUPAC name is 4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide.
| Compound Name | 4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide |
|---|---|
| PubChem CID | 157093225 |
| Molecular Formula | C157H170F2N30O7 |
| Molecular Weight | 2627.29 g/mol |
| Exact Mass | 2625.38 |
| IUPAC Name | 4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-3-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-3-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide |
| SMILES | CCCCn1ccc(-c2cc3c(NC4C5CC4C5)c(C(=O)NC4CC4)cnc3cc2F)n1.CCCCn1ccc(-c2cc3c(NCc4ccccc4)c(C(=O)NC4CC4)cnc3cc2CO)n1.CCCCn1ccc(-c2cc3c(Nc4ccccc4)c(C(=O)NC4CC4)cnc3cc2C)n1.CCCCn1ccc(-c2cc3c(Nc4ccccc4)c(C(=O)NC4CC4)cnc3cc2F)n1.CCCCn1ccc(-c2ccc3ncc(C(=O)NC(C)C)c(Nc4ccccc4)c3c2)n1.CCCCn1ccc(-c2ccc3ncc(C(=O)NCC)c(Nc4ccccc4)c3c2)n1 |
| InChI | InChI=1S/C28H31N5O2.C27H29N5O.C26H26FN5O.C26H29N5O.C25H28FN5O.C25H27N5O/c1-2-3-12-33-13-11-25(32-33)22-15-23-26(14-20(22)18-34)29-17-24(28(35)31-21-9-10-21)27(23)30-16-19-7-5-4-6-8-19;1-3-4-13-32-14-12-24(31-32)21-16-22-25(15-18(21)2)28-17-23(27(33)30-20-10-11-20)26(22)29-19-8-6-5-7-9-19;1-2-3-12-32-13-11-23(31-32)19-14-20-24(15-22(19)27)28-16-21(26(33)30-18-9-10-18)25(20)29-17-7-5-4-6-8-17;1-4-5-14-31-15-13-23(30-31)19-11-12-24-21(16-19)25(29-20-9-7-6-8-10-20)22(17-27-24)26(32)28-18(2)3;1-2-3-7-31-8-6-21(30-31)17-11-18-22(12-20(17)26)27-13-19(25(32)28-16-4-5-16)24(18)29-23-14-9-15(23)10-14;1-3-5-14-30-15-13-22(29-30)18-11-12-23-20(16-18)24(28-19-9-7-6-8-10-19)21(17-27-23)25(31)26-4-2/h4-8,11,13-15,17,21,34H,2-3,9-10,12,16,18H2,1H3,(H,29,30)(H,31,35);5-9,12,14-17,20H,3-4,10-11,13H2,1-2H3,(H,28,29)(H,30,33);4-8,11,13-16,18H,2-3,9-10,12H2,1H3,(H,28,29)(H,30,33);6-13,15-18H,4-5,14H2,1-3H3,(H,27,29)(H,28,32);6,8,11-16,23H,2-5,7,9-10H2,1H3,(H,27,29)(H,28,32);6-13,15-17H,3-5,14H2,1-2H3,(H,26,31)(H,27,28) |
| InChIKey | AEXHHCBURHSDPR-UHFFFAOYSA-N |
| XLogP | 32.33 |
| TPSA | 451.27 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 50 |
| Heavy Atoms | 196 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2627.29 |
| LogP ≤ 5 | 32.33 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 31 |